222 related articles for article (PubMed ID: 17403683)
1. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
2. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.
Hu R; Sharma SM; Bronisz A; Srinivasan R; Sankar U; Ostrowski MC
Mol Cell Biol; 2007 Jun; 27(11):4018-27. PubMed ID: 17403896
[TBL] [Abstract][Full Text] [Related]
3. The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).
Bronisz A; Carey HA; Godlewski J; Sif S; Ostrowski MC; Sharma SM
J Biol Chem; 2014 Jan; 289(1):326-34. PubMed ID: 24257758
[TBL] [Abstract][Full Text] [Related]
4. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
Sharma SM; Sif S; Ostrowski MC; Sankar U
J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
[TBL] [Abstract][Full Text] [Related]
5. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.
Matsumoto M; Kogawa M; Wada S; Takayanagi H; Tsujimoto M; Katayama S; Hisatake K; Nogi Y
J Biol Chem; 2004 Oct; 279(44):45969-79. PubMed ID: 15304486
[TBL] [Abstract][Full Text] [Related]
6. Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant.
Carey HA; Bronisz A; Cabrera J; Hildreth BE; Cuitiño M; Fu Q; Ahmad A; Toribio RE; Ostrowski MC; Sharma SM
J Cell Physiol; 2016 Mar; 231(3):630-40. PubMed ID: 26218069
[TBL] [Abstract][Full Text] [Related]
7. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
[TBL] [Abstract][Full Text] [Related]
8. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation.
Partington GA; Fuller K; Chambers TJ; Pondel M
Bone; 2004 Feb; 34(2):237-45. PubMed ID: 14962802
[TBL] [Abstract][Full Text] [Related]
9. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.
Mansky KC; Sankar U; Han J; Ostrowski MC
J Biol Chem; 2002 Mar; 277(13):11077-83. PubMed ID: 11792706
[TBL] [Abstract][Full Text] [Related]
10. Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.
Herbert BA; Valerio MS; Gaestel M; Kirkwood KL
PLoS One; 2015; 10(5):e0125387. PubMed ID: 25946081
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in enhancement of osteoclast formation by activin-A.
Kajita T; Ariyoshi W; Okinaga T; Mitsugi S; Tominaga K; Nishihara T
J Cell Biochem; 2018 Aug; 119(8):6974-6985. PubMed ID: 29737562
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
14. AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.
Pang M; Rodríguez-Gonzalez M; Hernandez M; Recinos CC; Seldeen KL; Troen BR
J Cell Biochem; 2019 Aug; 120(8):12382-12392. PubMed ID: 30816596
[TBL] [Abstract][Full Text] [Related]
15. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.
Crotti TN; Sharma SM; Fleming JD; Flannery MR; Ostrowski MC; Goldring SR; McHugh KP
J Cell Physiol; 2008 Jun; 215(3):636-44. PubMed ID: 18288635
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
18. Scoparone attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging.
Lee SH; Jang HD
Exp Cell Res; 2015 Feb; 331(2):267-77. PubMed ID: 25576385
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
Cao B; Dai X; Wang W
J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]